Trial
NCT05966584
A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
AstraZeneca; Novartis Pharmaceuticals
Condition
Breast Cancer
Intervention
Benralizumab
Why stopped
Limited amount of eligible participants
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-29